Two stocks in Healthcare
Fresenius SE & Co. KGaA vs Lonza Group: profit, growth, debt and price compared
Fresenius SE & Co. KGaA is stronger on 5 of 7 figures: profit margin, price for its expected profit, dividend, analysts' view and price trend. Lonza Group is stronger on 2: sales growth and debt.
Save both stocks to your watchlist and revisit their latest fundamentals.
| Fresenius SE & Co. KGaAFRE.DE | Lonza GroupLONN.SW | |
|---|---|---|
| Net margin | Stronger: 6.6% | −1.6% |
| Revenue growth, past year | +5.90% | Stronger: +11.20% |
| Debt to equity | 57.0% | Stronger: 51.1% |
| Forward P/E | Stronger: 13.7× | 29.7× |
| Dividend yield | Stronger: 1.95% | 0.75% |
| Analysts | Stronger: Strong buy · 14 | Buy · 23 |
| From its 200-day average | Stronger: +19.2% | +17.8% |
Share price over the past year
- Fresenius SE & Co. KGaA+14.2%
- Lonza Group+25.8%
20 Nov 202518 Nov 2026
Fresenius SE & Co. KGaA or Lonza Group: which is stronger?
- FRE.DE
Which is more profitable?
Fresenius SE & Co. KGaA keeps more of each sale as profit: 6.6% against −1.6%.
- LONN.SW
Which is growing its sales faster?
Lonza Group is growing its sales faster: +11.20% over the past year, against +5.90%.
- LONN.SW
Which has borrowed less?
Lonza Group has borrowed less: its debt is 51.1% of what its shareholders own, against 57.0% for Fresenius SE & Co. KGaA.
- FRE.DE
Which costs less for the profit it is expected to make?
Fresenius SE & Co. KGaA costs less for the profit it is expected to make: 13.7× its forward earnings, against 29.7×.
- FRE.DE
Which pays more in dividends?
Fresenius SE & Co. KGaA pays more back in dividends for what a share costs: 1.95% a year, against 0.75%.
- FRE.DE
Which do analysts rate higher?
Analysts are warmer on Fresenius SE & Co. KGaA: Strong buy, against Buy for Lonza Group.
- FRE.DE
Which is in the stronger price trend?
Fresenius SE & Co. KGaA's price is in the stronger trend: 19.2% above its 200-day average, against 17.8% above.
What each company does
FRE.DEFresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
Reports results on 24 February 2027
LONN.SWLonza Group
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, and internationally.
Reports results on 27 January 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.